Ensuring Patient Access to Critical Breakthrough Products Act
119-hr5343 — Ensuring Patient Access to Critical Breakthrough Products Act. Sponsored by Rep. Moore, Blake D. [R-UT-1]. Introduced 2025-09-15. House bill. 119th Congress. Latest action: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Bill Activity
House
Introduced in House
2025-09-15
Introduced
2025-09-15
Introduced in House
Reported from Committee
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Committee
2025-09-15
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committee
2025-09-17
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
- Sponsor
- Rep. Moore, Blake D. [R-UT-1] (R), UT
- Introduced
- 2025-09-15
- Committees
- Ways and Means Committee; Energy and Commerce Committee
- Subjects
- Congressional oversight; Drug safety, medical device, and laboratory regulation; Health care costs and insurance; Health care coverage and access; Health programs administration and funding; Health technology, devices, supplies; Medicare
- Latest Action
- Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
No roll-call vote data available for this bill.
Explore This Bill
Investigate this bill → AI summary, roll-call breakdown, and full bill analysis